Ultralife (NASDAQ:ULBI) Announces Quarterly Earnings Results

Ultralife (NASDAQ:ULBIGet Free Report) released its earnings results on Friday. The technology company reported ($0.03) earnings per share for the quarter, missing the consensus estimate of $0.15 by ($0.18), Zacks reports. Ultralife had a negative net margin of 3.09% and a positive return on equity of 3.10%.

Here are the key takeaways from Ultralife’s conference call:

  • Q1 revenue was $47.4 million with an operating loss of $0.2 million and a net loss of $0.5 million (?$0.03/sh), attributed to shipment timing, Middle East delivery delays, plant reorganizations, weather-related interruptions, and pre?revenue staffing and consulting costs.
  • Consolidated gross margin dropped to 21.3% (down 380 bps) and gross profit fell 20.7% year?over?year, driven largely by lost production days (Newark substation failure and a 16?day equivalent impact at Raynham during ERP/inventory transition), higher energy costs, and unfavorable sales mix/tariffs.
  • The company exited Q1 with a record backlog of $115.1 million (up 21% YoY), representing 61% of trailing?12?month sales and including over $12 million of new?product backlog, providing stronger near?term revenue visibility.
  • Management is investing in product development and vertical integration (Electrochem), expects to more than double internal cell usage, shipped the first conformal wearable battery order with > $8 million backlog, and won a $4 million multi?year award—actions intended to stabilize Communications Systems revenue and lift gross margins.

Ultralife Trading Down 15.3%

NASDAQ ULBI traded down $1.08 during trading on Friday, hitting $5.97. The stock had a trading volume of 131,366 shares, compared to its average volume of 44,552. The company has a market capitalization of $99.46 million, a PE ratio of -16.58 and a beta of 0.74. The company has a quick ratio of 1.39, a current ratio of 2.83 and a debt-to-equity ratio of 0.35. The firm has a 50 day moving average price of $6.64 and a 200 day moving average price of $6.30. Ultralife has a twelve month low of $4.78 and a twelve month high of $9.52.

Hedge Funds Weigh In On Ultralife

Several institutional investors have recently bought and sold shares of the company. Janney Montgomery Scott LLC grew its position in Ultralife by 6.8% in the 4th quarter. Janney Montgomery Scott LLC now owns 507,800 shares of the technology company’s stock valued at $2,905,000 after acquiring an additional 32,133 shares in the last quarter. Arrowstreet Capital Limited Partnership grew its position in Ultralife by 210.8% in the 3rd quarter. Arrowstreet Capital Limited Partnership now owns 219,018 shares of the technology company’s stock valued at $1,494,000 after acquiring an additional 148,542 shares in the last quarter. Raymond James Financial Inc. grew its position in shares of Ultralife by 14.5% during the second quarter. Raymond James Financial Inc. now owns 116,085 shares of the technology company’s stock worth $1,042,000 after buying an additional 14,667 shares in the last quarter. Ancora Advisors LLC grew its position in shares of Ultralife by 24.3% during the third quarter. Ancora Advisors LLC now owns 105,321 shares of the technology company’s stock worth $718,000 after buying an additional 20,562 shares in the last quarter. Finally, Citadel Advisors LLC grew its position in shares of Ultralife by 78.9% during the third quarter. Citadel Advisors LLC now owns 80,921 shares of the technology company’s stock worth $552,000 after buying an additional 35,695 shares in the last quarter. 30.68% of the stock is owned by institutional investors and hedge funds.

Ultralife Company Profile

(Get Free Report)

Ultralife Corporation (NASDAQ: ULBI) develops, manufactures and sells a broad range of energy and communications products for defense, medical, automotive and consumer electronics markets. The company operates through two primary segments: Power Systems and Communications Systems. In its Power Systems segment, Ultralife produces lithium-ion rechargeable cells and battery packs, primary lithium batteries, alkaline and rechargeable battery packs, chargers and battery accessories designed to meet demanding performance and safety requirements.

See Also

Earnings History for Ultralife (NASDAQ:ULBI)

Receive News & Ratings for Ultralife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ultralife and related companies with MarketBeat.com's FREE daily email newsletter.